Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo

Leukemia

Volumn 23, Issue 9, 2009, Pages 1650-1657

  Qian, Z ^a   Mao, L ^a   Fernald, A A ^a   Yu, H ^a   Luo, R ^a   Jiang, Y ^a   Anastasi, J ^a   Valk, P J ^b   Delwel, R ^b   Le Beau, M M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukemia; Apoptosis; FHL2; Granulopoiesis; Megakaryocytopoiesis; proliferation

Indexed keywords

FHL2 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; MUSCLE PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; GENETICS; HEMATOPOIESIS; MALE; MOUSE; MYELOID PROGENITOR CELL; MYELOPOIESIS; PHYSIOLOGY; THROMBOCYTOPOIESIS;

ANIMALS; CELL PROLIFERATION; HEMATOPOIESIS; HOMEODOMAIN PROTEINS; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUSCLE PROTEINS; MYELOID PROGENITOR CELLS; MYELOPOIESIS; THROMBOPOIESIS; TRANSCRIPTION FACTORS;

EID: 70349319991     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.78     Document Type: Article

References (26)

1. Pedersen-Bjergaard J. Insights into leukemogenesis from therapyrelated leukemia. N Engl J Med 2005; 352: 1591-1594.
2. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102: 43-52.
3. Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA 2002; 99: 14925-14930.
4. Genini M, Schwalbe P, Scholl FA, Remppis A, Mattei MG, Schafer BW. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol 1997; 16: 433-442.
5. Bach I. The LIM domain: regulation by association. Mech Dev 2000; 91: 5-17.
6. Johannessen M, Moller S, Hansen T, Moens U, Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol Life Sci 2006; 63: 268-284.
7. Chu PH, Bardwell WM, Gu Y, Ross Jr J, Chen J. FHL2 (SLIM3) is not essential for cardiac development and function. Mol Cell Biol 2000; 20: 7460-7462.
8. Kong Y, Shelton JM, Rothermel B, Li X, Richardson JA, Bassel-Duby R et al. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation 2001; 103: 2731-2738.
9. Gunther T, Poli C, Muller JM, Catala-Lehnen P, Schinke T, Yin N et al. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J 2005; 24: 3049-3056.
10. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996; 70: 5701-5705.
11. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 1997; 16: 4226-4237.
12. Qian Z, Chen L, Fernald AA, Williams BO, Le Beau MM. A critical role for Apc in hematopoietic stem and progenitor cell survival. J Exp Med 2008; 205: 2163-2175.
13. Qian Z, Okuhara D, Abe MK, Rosner MR. Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel. J Biol Chem 1999; 274: 1621-1627.
14. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617-1628.
15. Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 2006; 108: 685-696.
16. Scholl FA, McLoughlin P, Ehler E, de Giovanni C, Schafer BW. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol 2000; 151: 495-506.
17. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. Ineffective erythropoiesis in Stat5a(r/f)5b(f/r) mice due to decreased survival of early erythroblasts. Blood 2001; 98: 3261-3273.
18. Labalette C, Nouet Y, Sobczak-Thepot J, Armengol C, Levillayer F, Gendron MC et al. The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. J Biol Chem2008; 283: 15201-15208.
19. Paul C, Lacroix M, Iankova I, Julien E, Schafer BW, Labalette C et al. The LIM-only protein FHL2 is a negative regulator of E4F1. Oncogene 2006; 25: 5475-5484.
20. Martin BT, Kleiber K, Wixler V, Raab M, Zimmer B, Kaufmann M et al. FHL2 regulates cell cycle-dependent and doxorubicininduced p21Cip1/Waf1 expression in breast cancer cells. Cell Cycle 2007; 6: 1779-1788.
21. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z et al. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995; 48: 143-154.
22. Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C et al. Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem 2003; 278: 5188-5194.
23. Gabriel B, Mildenberger S, Weisser CW, Metzger E, Gitsch G, Schule R et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res 2004; 24: 921-927.
24. Muller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R et al. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 2002; 21: 736-748.
25. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119-128.
26. Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002; 109: 321-334.